COVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies

Simple item page
dc.contributor.authorVerdugo-Paiva, Francisca
dc.contributor.authorVergara, Camilo
dc.contributor.authorAvila, Camila
dc.contributor.authorCastro-Guevara, Javier A.
dc.contributor.authorCid, Josefina
dc.contributor.authorContreras, Valeria
dc.contributor.authorJara, Ivan
dc.contributor.authorJimenez, Valentina
dc.contributor.authorLee, Min Ha
dc.contributor.authorMunoz, Magdalena
dc.contributor.authorRojas-Gomez, Ana Maria
dc.contributor.authorRoson-Rodriguez, Pablo
dc.contributor.authorSerrano-Arevalo, Karen
dc.contributor.authorSilva-Ruz, Ivan
dc.contributor.authorVasquez-Laval, Juan
dc.contributor.authorZambrano-Achig, Paula
dc.contributor.authorZavadzki, Giovanna
dc.contributor.authorRada, Gabriel
dc.date.accessioned2025-01-20T21:02:59Z
dc.date.available2025-01-20T21:02:59Z
dc.date.issued2022
dc.description.abstractBackground and Objective: The coronavirus disease 2019 Living OVerview of Evidence (COVID-19 L$OVE) is a public repository and classification platformforCOVID-19 articles. The repository containsmore than 430,000 articles as of September 20, 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews.
dc.description.abstractMethods: Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L$OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L$OVE repository. We estimated the currency as the percentage of studies that was available in the COVID-19 L$OVE repository at the time the systematic reviews conducted their own search.
dc.description.abstractResults: We identified 83 eligible systematic reviews that included 2,132 studies. COVID-19 L$OVE had an overall comprehensiveness of 99.67% (2,125/2,132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L$OVE instead of searching the original sources, was 96.48% (2,057/2,132). Both the comprehensiveness and the currency were 100% for randomized trials (82/82).
dc.description.abstractConclusion: The COVID-19 L$OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processes.
dc.description.abstract(c) 2022 Elsevier Inc. All rights reserved.
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.jclinepi.2022.05.001
dc.identifier.eissn1878-5921
dc.identifier.issn0895-4356
dc.identifier.urihttps://doi.org/10.1016/j.jclinepi.2022.05.001
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/93110
dc.identifier.wosidWOS:001072981700001
dc.language.isoen
dc.pagina.final202
dc.pagina.inicio195
dc.revistaJournal of clinical epidemiology
dc.rightsacceso restringido
dc.subjectComprehensiveness
dc.subjectCurrency
dc.subjectRepository
dc.subjectCOVID-19
dc.subjectLiving OVerview of Evidence
dc.subjectDatabase
dc.subjectSearch retrieval
dc.subjectSensitivity
dc.subjectSystematic review
dc.subjectSARS-CoV-2
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleCOVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies
dc.typeartículo
dc.volumen149
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas